Page last updated: 2024-08-21

myristic acid and ro 25-1553

myristic acid has been researched along with ro 25-1553 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cnudde, J; De Neef, P; Gourlet, P; Moreno, D; Robberecht, P; Waelbroeck, M	1

Other Studies

1 other study(ies) available for myristic acid and ro 25-1553

Article	Year
Development of selective agonists and antagonists for the human vasoactive intestinal polypeptide VPAC(2) receptor. Peptides, 2000, Volume: 21, Issue:10 Topics: Acylation; Adenylyl Cyclases; Amino Acid Sequence; Animals; Binding, Competitive; CHO Cells; Cricetinae; Drug Design; Enzyme Activation; Humans; Inhibitory Concentration 50; Molecular Sequence Data; Myristic Acid; Peptide Fragments; Peptides, Cyclic; Receptors, Vasoactive Intestinal Peptide; Receptors, Vasoactive Intestinal Peptide, Type II; Receptors, Vasoactive Intestinal Polypeptide, Type I; Recombinant Proteins; Substrate Specificity; Vasoactive Intestinal Peptide; Vasodilator Agents	2000

Article

Year

Development of selective agonists and antagonists for the human vasoactive intestinal polypeptide VPAC(2) receptor.

Peptides, 2000, Volume: 21, Issue:10

Topics: Acylation; Adenylyl Cyclases; Amino Acid Sequence; Animals; Binding, Competitive; CHO Cells; Cricetinae; Drug Design; Enzyme Activation; Humans; Inhibitory Concentration 50; Molecular Sequence Data; Myristic Acid; Peptide Fragments; Peptides, Cyclic; Receptors, Vasoactive Intestinal Peptide; Receptors, Vasoactive Intestinal Peptide, Type II; Receptors, Vasoactive Intestinal Polypeptide, Type I; Recombinant Proteins; Substrate Specificity; Vasoactive Intestinal Peptide; Vasodilator Agents

2000